1. Home
  2. ICUCW vs FCNCO Comparison

ICUCW vs FCNCO Comparison

Compare ICUCW & FCNCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUCW
  • FCNCO
  • Stock Information
  • Founded
  • ICUCW N/A
  • FCNCO 1898
  • Country
  • ICUCW United States
  • FCNCO United States
  • Employees
  • ICUCW 19
  • FCNCO N/A
  • Industry
  • ICUCW Biotechnology: Pharmaceutical Preparations
  • FCNCO Major Banks
  • Sector
  • ICUCW Health Care
  • FCNCO Finance
  • Exchange
  • ICUCW Nasdaq
  • FCNCO Nasdaq
  • Market Cap
  • ICUCW N/A
  • FCNCO N/A
  • IPO Year
  • ICUCW 2021
  • FCNCO N/A
  • Fundamental
  • Price
  • ICUCW $0.03
  • FCNCO $21.56
  • Analyst Decision
  • ICUCW
  • FCNCO
  • Analyst Count
  • ICUCW 0
  • FCNCO 0
  • Target Price
  • ICUCW N/A
  • FCNCO N/A
  • AVG Volume (30 Days)
  • ICUCW N/A
  • FCNCO 22.3K
  • Earning Date
  • ICUCW N/A
  • FCNCO 07-24-2025
  • Dividend Yield
  • ICUCW N/A
  • FCNCO 6.52%
  • EPS Growth
  • ICUCW N/A
  • FCNCO N/A
  • EPS
  • ICUCW N/A
  • FCNCO 175.01
  • Revenue
  • ICUCW N/A
  • FCNCO $9,091,000,000.00
  • Revenue This Year
  • ICUCW N/A
  • FCNCO N/A
  • Revenue Next Year
  • ICUCW N/A
  • FCNCO $2.30
  • P/E Ratio
  • ICUCW N/A
  • FCNCO $9.69
  • Revenue Growth
  • ICUCW N/A
  • FCNCO N/A
  • 52 Week Low
  • ICUCW N/A
  • FCNCO $20.57
  • 52 Week High
  • ICUCW N/A
  • FCNCO $24.83
  • Technical
  • Relative Strength Index (RSI)
  • ICUCW N/A
  • FCNCO 38.24
  • Support Level
  • ICUCW N/A
  • FCNCO $21.35
  • Resistance Level
  • ICUCW N/A
  • FCNCO $21.62
  • Average True Range (ATR)
  • ICUCW 0.00
  • FCNCO 0.27
  • MACD
  • ICUCW 0.00
  • FCNCO -0.14
  • Stochastic Oscillator
  • ICUCW 0.00
  • FCNCO 20.00

About ICUCW SeaStar Medical Holding Corporation Warrant

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through our extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

Share on Social Networks: